Asymchem Laboratories Tian Jin Co Ltd (002821) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Asymchem Laboratories Tian Jin Co Ltd (002821) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥449.89 Million ≈ $65.83 Million USD) by net assets (CN¥17.36 Billion ≈ $2.54 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Asymchem Laboratories Tian Jin Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Asymchem Laboratories Tian Jin Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Asymchem Laboratories Tian Jin Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Asymchem Laboratories Tian Jin Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Asymchem Laboratories Tian Jin Co Ltd ranked by their cash flow conversion efficiency. Explore Asymchem Laboratories Tian Jin Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Syensqo
BR:SYENS
0.050x
Jiangsu Etern Co Ltd
SHG:600105
0.016x
The Hanover Insurance Group Inc
NYSE:THG
0.058x
CelcomDigi Berhad
KLSE:6947
0.030x
Deutsche Wohnen SE
F:DWNI
0.029x
Baiyin Nonferrous Group Co Ltd
SHG:601212
0.041x
Renault SA
F:RNL1
0.024x
Als Ltd
AU:ALQ
0.127x

Annual Cash Flow Conversion Efficiency for Asymchem Laboratories Tian Jin Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Asymchem Laboratories Tian Jin Co Ltd from 2011 to 2025. View Asymchem Laboratories Tian Jin Co Ltd (002821) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥17.65 Billion
≈ $2.58 Billion
CN¥1.41 Billion
≈ $205.97 Million
0.080x +7.23%
2024-12-31 CN¥16.86 Billion
≈ $2.47 Billion
CN¥1.25 Billion
≈ $183.55 Million
0.074x -63.31%
2023-12-31 CN¥17.51 Billion
≈ $2.56 Billion
CN¥3.55 Billion
≈ $519.44 Million
0.203x -3.20%
2022-12-31 CN¥15.70 Billion
≈ $2.30 Billion
CN¥3.29 Billion
≈ $480.98 Million
0.209x +2233.93%
2021-12-31 CN¥12.61 Billion
≈ $1.85 Billion
CN¥113.15 Million
≈ $16.56 Million
0.009x -90.56%
2020-12-31 CN¥5.99 Billion
≈ $876.49 Million
CN¥569.29 Million
≈ $83.31 Million
0.095x -51.83%
2019-12-31 CN¥3.05 Billion
≈ $445.65 Million
CN¥600.87 Million
≈ $87.93 Million
0.197x +19.34%
2018-12-31 CN¥2.51 Billion
≈ $367.38 Million
CN¥415.06 Million
≈ $60.74 Million
0.165x +81.41%
2017-12-31 CN¥2.16 Billion
≈ $315.35 Million
CN¥196.40 Million
≈ $28.74 Million
0.091x -39.99%
2016-12-31 CN¥1.83 Billion
≈ $268.22 Million
CN¥278.36 Million
≈ $40.73 Million
0.152x -44.63%
2015-12-31 CN¥937.02 Million
≈ $137.12 Million
CN¥256.99 Million
≈ $37.61 Million
0.274x +69.50%
2014-12-31 CN¥785.17 Million
≈ $114.90 Million
CN¥127.05 Million
≈ $18.59 Million
0.162x +4.81%
2013-12-31 CN¥686.10 Million
≈ $100.40 Million
CN¥105.92 Million
≈ $15.50 Million
0.154x +173.00%
2012-12-31 CN¥608.06 Million
≈ $88.98 Million
CN¥34.38 Million
≈ $5.03 Million
0.057x +18.47%
2011-12-31 CN¥542.26 Million
≈ $79.35 Million
CN¥25.88 Million
≈ $3.79 Million
0.048x --

About Asymchem Laboratories Tian Jin Co Ltd

SHE:002821 China Biotechnology
Market Cap
$7.94 Billion
CN¥54.28 Billion CNY
Market Cap Rank
#2669 Global
#314 in China
Share Price
CN¥163.02
Change (1 day)
-3.09%
52-Week Range
CN¥89.50 - CN¥195.75
All Time High
CN¥358.21
About

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, incl… Read more